Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine added to bupivacaine for lower limb orthopedic surgery
IRCT20130803014251N12Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Bupivacaine + dexmedetomidine with Bupivacaine + saline (2 arms). Primary endpoint: Postoperative pain intensity. Started Jul 2026; status: completed.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20130803014251N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130803014251N12.